Cart
sales@molnova.com
SCH-527123
CAS No. 473727-83-2
SCH-527123( SCH527123 | Navarixin | SCH 527123 | MK-7123 )
Catalog No. M14572 CAS No. 473727-83-2
A potent, selective, orally bioavailable CXCR2/CXCR1 receptor antagonist with Kd of 0.08 and 41 nM for cynomolgus CXCR2 and CXCR1, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 80 | In Stock |
|
| 10MG | 120 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 50MG | 357 | In Stock |
|
| 100MG | 537 | In Stock |
|
| 500MG | 1188 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSCH-527123
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, orally bioavailable CXCR2/CXCR1 receptor antagonist with Kd of 0.08 and 41 nM for cynomolgus CXCR2 and CXCR1, respectively.
-
DescriptionA potent, selective, orally bioavailable CXCR2/CXCR1 receptor antagonist with Kd of 0.08 and 41 nM for cynomolgus CXCR2 and CXCR1, respectively; potently inhibits CXCR2-mediated chemotaxis with IC50 of 3-6 nM; inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation.COPD Phase 2 Discontinued.
-
In Vitro——
-
In Vivo——
-
SynonymsSCH527123 | Navarixin | SCH 527123 | MK-7123
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research AreaInflammation/Immunology
-
IndicationCOPD
Chemical Information
-
CAS Number473727-83-2
-
Formula Weight397.4244
-
Molecular FormulaC21H23N3O5
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(N(C)C)C1=CC=CC(NC2=C(N[C@@H](C3=CC=C(C)O3)CC)C(C2=O)=O)=C1O
-
Chemical NameBenzamide, 2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chapman RW, et al. J Pharmacol Exp Ther. 2007 Aug;322(2):486-93.
2. Dwyer MP, et al. J Med Chem. 2006 Dec 28;49(26):7603-6.
3. Gonsiorek W, et al. J Pharmacol Exp Ther. 2007 Aug;322(2):477-85.
4. Singh S, et al. Clin Cancer Res. 2009 Apr 1;15(7):2380-6.
molnova catalog
related products
-
BMS-681
A potent and orally bioavailable dual antagonist of CCR2 and CCR5 with binding IC50 of 0.7 nM and 2.4 nM, respectively.
-
IT1t
A highly potent, selective, orally bioavailable CXCR4 inhibitor with binding IC50 of 8 nM for hCXCR4, IC50 of 1.1 nM in Ca2+-mobilization assays.
-
ML 604086
ML 604086 (ML604086) is a potent, selective CCR8 inhibitor that inhibits CCL1 mediated chemotaxis and increases in intracellular Ca2+ concentrations with IC50 of 1.3?uM and 1.0?uM respectively in cellular assays.
